Effects of Intravenous Administration of Fibrinolysin (Plasmin) in Man

The potentiality of dissolving clots has aroused great interest in fibrinolysin (plasmin) as a therapeutic agent in thromboembolism. In this paper the effects of intravenous administration of purified fibrinolysin in man are reported, with special emphasis upon systemic toxicity and alterations in clotting factors and fibrinolytic activity. This information is necessary for the evaluation of this agent for clinical purposes.

[1]  E. Cliffton.  The use of plasmin in humans. , 1959, Annals of the New York Academy of Sciences.

[2]  T. McDONALD,et al.  The effect of heparin on components of the human fibrinolytic system. , 1958, Blood.

[3]  K. V. von Kaulla.  Intravenous Protein‐Free Pyrogen: A Powerful Fibrinolytic Agent in Man , 1958, Circulation.

[4]  K. V. Kaulla,et al.  Intravenous protein-free pyrogen; a powerful fibrinolytic agent in man. , 1958 .

[5]  W. B. Wood,et al.  STUDIES ON THE PATHOGENESIS OF FEVER , 1958, The Journal of Experimental Medicine.

[6]  N. Back,et al.  CLINICAL AND EXPERIMENTAL STUDIES ON FIBRINOLYTIC ENZYMES , 1957, Annals of the New York Academy of Sciences.

[7]  W. Tillett,et al.  THE INTRAVASCULAR USE OF STREPTOKINASE , 1957, Annals of the New York Academy of Sciences.

[8]  E. Cliffton,et al.  THE USE OF PLASMIN IN HUMANS , 1957 .

[9]  S. Müllertz.  ACTIVATION OF PLASMINOGEN , 1957 .

[10]  J. Lewis,et al.  Differential diagnosis and treatment in hemorrhagic disease. , 1957, A.M.A. archives of internal medicine.

[11]  W. Tillett,et al.  Effects in Patients of Intravenous Infusions of Purified Streptokinase Preparations.∗ , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[12]  F. Ablondi,et al.  Stability of the Activator of Bovine Plasminogen , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[13]  T. Rees,et al.  Treatment of infected wounds and chronic sinus tracts with enzymes; plasmin (fibrinolysin) and hyaluronidase and antibiotics. , 1956, American journal of surgery.

[14]  T. Astrup,et al.  The biological significance of fibrinolysis. , 1956, Lancet.

[15]  N. Back,et al.  In Vivo Fibrinolytic Activity and Pharmacology of Various Plasmin (Fibrinolysin) Preparations , 1956, Circulation research.

[16]  J. B. Fishman,et al.  Isolation of Partially Purified Human Plasmin (Fibrinolysin) , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  W. Tillett,et al.  The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients. , 1955, The Journal of clinical investigation.

[18]  I. Wright,et al.  Studies with crystalline trypsin: results and hazards of intravenous administration and its postulated role in blood coagulation. , 1954, Journal of the American Medical Association.

[19]  S. Sherry,et al.  The action of plasmin on synthetic substrates. , 1954, The Journal of biological chemistry.

[20]  C. Grossi,et al.  LYSIS OF THROMBI PRODUCED BY SODIUM MORRHUATE IN THE FEMORAL VEIN OF DOGS BY HUMAN PLASMIN (FIBRINOLYSIN) , 1954, Annals of surgery.

[21]  E. Cliffton,et al.  Fibrinolytic and proteolytic activity of a human plasminogen, prepared from fraction III of human plasma. , 1953, Journal of applied physiology.

[22]  H. Wright,et al.  Recanalization of Thrombosed Arteries Under Anticoagulant Therapy , 1953, British medical journal.

[23]  H. Laufman,et al.  Intravenous trypsin in the treatment of thrombotic phenomena. , 1953, A.M.A. archives of surgery.

[24]  A. Angrist,et al.  Intravenous trypsin; its anticoagulant, fibrinolytic and thrombolytic effects. , 1952, The Journal of clinical investigation.

[25]  H. Wright,et al.  Influence of anticoagulant administration on the rate of recanalization of experimentally thrombosed veins , 1952, The British journal of surgery.

[26]  J. Lewis,et al.  Studies on a proteolytic enzyme system of the blood. V. Activation of profibrinolysin by trypsin. , 1952, The American journal of physiology.

[27]  I. L. Bennett,et al.  The properties and biologic effects of bacterial pyrogens. , 1950, Medicine.

[28]  P. Cohen,et al.  Partial purification and properties of a proteolytic enzyme of human serum. , 1949, The Journal of biological chemistry.

[29]  J. Edsall,et al.  Preparation and properties of serum and plasma proteins; the separation of purified fibrinogen from fraction I of human plasma. , 1948, Journal of the American Chemical Society.

[30]  M. H. Kaplan,et al.  STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. II. THE INHIBITION OF STREPTOCOCCAL FIBRINOLYSIS BY ANTIFIBRINOLYSIN AND ANTIPROTEASE. , 1946, The Journal of clinical investigation.

[31]  C. Macleod,et al.  A PROTEOLYTIC ENZYME OF SERUM: CHARACTERIZATION, ACTIVATION, AND REACTION WITH INHIBITORS , 1945, The Journal of general physiology.

[32]  A. Quick.  The physiology and pathology of hemostasis , 1951 .

[33]  A. Ryder,et al.  Fibrinolysin; nomenclature, unit, assay, preparation and properties. , 1947, Archives of biochemistry.